Glen Weiss, MD, MBA
Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II […] Read more
David Spigel, MD
David Spigel has been appointed chief scientific officer of Sarah Cannon Research Institute, Nashville, US, and will oversee the development and operations of Sarah Cannon’s clinical research program. Dr. Spigel joined […] Read more
Mark A. Socinski, MD
Mark A. Socinski has been appointed Executive Medical Director of the Florida Hospital Cancer Institute, and will oversee the coordination of clinical cancer services for the Florida Hospital network. He will […] Read more
David H. Johnson, MD
David H. Johnson received the 2016 ASCO Distinguished Achievement Award, which is given annually and recognizes leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer […] Read more
Jeffrey Engelman has been appointed Vice President and Global Head of Oncology at the Novartis Institutes of BioMedical Research. Prior to joining Novartis, Dr. Engelman was Director of the Center for […] Read more
Laurie Fenton Ambrose
Laurie Fenton Ambrose received the 2016 James L. Mulshine, MD Leadership Award, which recognized her efforts in guiding patient advocacy and other stakeholder groups in the successful efforts to gain […] Read more
Jean-Marie Cuillerot, MD
Jean-Marie Cuillerot has been appointed Vice President and Global Head of Clinical Development at Agenus, Inc, Lexington, US, overseeing ongoing clinical development of checkpoint targeted antibodies, including AGEN1884 targeting CTLA-4 and […] Read more
Anton Berns, PhD, FAACR
Anton Berns was elected to the National Academy of Sciences (NAS). NAS membership is in recognition of distinguished and continuing achievements in original research. Dr. Berns is the Senior Group Leader […] Read more
By Cynthia L. Kryder, MS IASLC Lung Cancer News recently spoke with Kapil Dhingra, MD, of KAPital Consulting LLC in Sparta, New Jersey, about oncologic drug development and the challenges […] Read more
Next-Generation Sequencing Across the World: Reports from France, Germany, and China
Next-generation sequencing (NGS) technology has revolutionized genomic and genetic research as it fulfills its potential to tailor the treatment of cancer patients in general and non-small cell lung cancer (NSCLC) […] Read more